BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6376703)

  • 21. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J; Michalik M; Reiss J; Grzybowski J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme.
    Sonnabend WF; Sonnabend UP; Krech T
    Appl Environ Microbiol; 1987 Aug; 53(8):1880-4. PubMed ID: 3116935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the spore surface and exosporium proteins of Clostridium sporogenes; implications for Clostridium botulinum group I strains.
    Janganan TK; Mullin N; Tzokov SB; Stringer S; Fagan RP; Hobbs JK; Moir A; Bullough PA
    Food Microbiol; 2016 Oct; 59():205-12. PubMed ID: 27375261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological identification of Bacteroides species by an enzyme-linked immunosorbent assay.
    Poxton IR
    J Clin Pathol; 1979 Mar; 32(3):294-8. PubMed ID: 34633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of Genome-Based Discrimination between Clostridium botulinum Group I and Clostridium sporogenes Strains for Bacterial Taxonomy.
    Weigand MR; Pena-Gonzalez A; Shirey TB; Broeker RG; Ishaq MK; Konstantinidis KT; Raphael BH
    Appl Environ Microbiol; 2015 Aug; 81(16):5420-9. PubMed ID: 26048939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of EDTA-soluble cell surface components of gram-positive anaerobic cocci.
    Smith GL; Cumming CG; Ross PW
    J Gen Microbiol; 1986 Jun; 132(6):1591-7. PubMed ID: 3806050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demonstration of 2 main serological groups in Clostridium tyrobutyricum].
    Bergère JL
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(1):75-91. PubMed ID: 2417541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type E toxin.
    Notermans S; Dufrenne J; Kozaki S
    Appl Environ Microbiol; 1979 Jun; 37(6):1173-5. PubMed ID: 384908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of toxigenic Clostridium botulinum type E by enzyme immunoassay.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1991; 14(1):11-5. PubMed ID: 2013205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunochemical fingerprinting of Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and diarrhoea.
    Poxton IR; Aronsson B; Möllby R; Nord CE; Collee JG
    J Med Microbiol; 1984 Jun; 17(3):317-24. PubMed ID: 6726785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of species-specific and cross-reactive cell-surface antigens of Bacteroides species by an indirect enzyme-linked immunosorbent assay.
    Poxton IR; Brown R; Collee JG
    J Med Microbiol; 1982 May; 15(2):223-31. PubMed ID: 7143430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium sporogenes isolates and their relationship to C. botulinum based on deoxyribonucleic acid reassociation.
    Nakamura S; Okado I; Nakashio S; Nishida S
    J Gen Microbiol; 1977 Jun; 100(2):395-401. PubMed ID: 330814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological studies of Clostridium botulinum type E and related organisms.
    Lynt RK; Solomon HM; Kautter DA; Lilly T
    J Bacteriol; 1967 Jan; 93(1):27-35. PubMed ID: 5335894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescent-antibody reagents for the identification of Clostridium botulinum.
    Glasby C; Hatheway CL
    J Clin Microbiol; 1983 Dec; 18(6):1378-83. PubMed ID: 6361053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies for use in detection of Bacillus and Clostridium spores.
    Quinlan JJ; Foegeding PM
    Appl Environ Microbiol; 1997 Feb; 63(2):482-7. PubMed ID: 9023926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of common antigens on cell surface of Clostridium chauvoei and C. septicum by indirect-immunofluorescence assay.
    Hamaoka T; Terakado N
    J Vet Med Sci; 1994 Apr; 56(2):371-3. PubMed ID: 8075228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic properties of four serotypes of Pasteurella multocida determined by enzyme-linked immunosorbent assay.
    Avakian AP; Dick JW
    Avian Dis; 1986; 30(3):477-81. PubMed ID: 3767808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.